The global Intragastric Weight Loss Balloon market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Intragastric Weight Loss Balloon Industry Forecast” looks at past sales and reviews total world Intragastric Weight Loss Balloon sales in 2023, providing a comprehensive analysis by region and market sector of projected Intragastric Weight Loss Balloon sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Intragastric Weight Loss Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyzes the strategies of leading global companies with a focus on Intragastric Weight Loss Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intragastric Weight Loss Balloon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intragastric Weight Loss Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

United States market for Intragastric Weight Loss Balloon is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Intragastric Weight Loss Balloon is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Intragastric Weight Loss Balloon is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Intragastric Weight Loss Balloon players cover:

• Spatz3
• Apollo Endosurgery
• Obalon Therapeutics
• ReShape Lifesciences
• Allurion Technologies

This report presents a comprehensive overview, market shares, and growth opportunities of Intragastric Weight Loss Balloon market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Swallowing
• Implantable

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration:

• Spatz3
• Apollo Endosurgery
• Obalon Therapeutics
• ReShape Lifesciences
• Allurion Technologies
• MEDSIL
• Silimed
• Endalis
• Districlass Médical
• Helioscopie
• Districlass Medical
• Lexel

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Intragastric Weight Loss Balloon market?
2. What factors are driving Intragastric Weight Loss Balloon market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Intragastric Weight Loss Balloon market opportunities vary by end market size?
5. How does Intragastric Weight Loss Balloon break out by Type, by Application?